Search Results: resolution/ (3)

trump-nov3_mikegaliciaMike Galicia

The president-elect may not be a hardliner, but he’s surrounded himself with them.

Here’s your daily round-up of pot-news, excerpted from the newsletter WeedWeek

The all-but-final Election Day tally is California, Massachusetts, Nevada and Maine legalized REC, whileFlorida, Arkansas, and North Dakota legalized MED.

Arizona rejected a REC measure. Montanans voted to allow a MED industry, though it remains contentious.

Arkansas Governor Asa Hutchinson (R), a legalization opponent and former DEA chief, said the process requires federal input. “It’s an example of the states innovating in a risky area, and certainly the states are leading on this, but we’re to a point that the federal government is going to have to readdress this,” he said. “This does not call for a state-by-state solution, it calls for … a national solution.”

This is an early indication that the cannabis industry will be harder for the Donald Trump administration to ignore than it was for the Obama administration.

Vice president elect Mike Pence (R) has replaced New Jersey Governor Chris Christie as head of Trump’s transition team. Both are known for their hardline stances against legalization, as is former New York City Mayor, Rudy Giuliani, a possible attorney general in the administration.

Several pieces speculate on what a Trump presidency means for legalization. Here are three:  The Cannabist, MJBiz, Reveal (Center for Investigative Reporting).

Drug Policy Alliance head Ethan Nadelmann said, “the federal government retains the power to hobble much of what we’ve accomplished…The progress we’ve made … will be very much at risk when Donald Trump enters the White House.”

Vivian Azer, a stock analyst with Cowen, predicts cannabis will be a low priority for Trump.

Rep. Earl Blumenauer (D.-Ore.), probably pot’s best friend in Congress, said he thinks the industry’s priorities for banking and tax reform could both pass a Republican Congress under President Trump.

 

sb10064721j-001.jpegadmin | Toke of the Town
The total is still below 15%.
The following is excerpted from the newsletter WeedWeek. Get your free and confidential subscription at WeedWeek.net.
A Gallup poll found that 13% of U.S. adults currently use cannabis, up from 7% in 2013.

At SFWeekly, I argued that the 2016 Presidential candidates have dodged their responsibility to discuss legalization.

Ohio is looking for an experienced pot grower to help write the state’s MED rules. The successful applicant will likely have to pass a drug test.

Some Ohio communities are taking action to keep out MED businesses, though dispensaries won’t open in the state until at least 2018.
The alcohol industry wants Congress to know that cannabis-impaired driving is a problem. Officially, the Wine & Spirits Wholesalers of America is neutral on legalization, but this year an industry group donated to stop Arizona’s REC initiative.
The San Jose Mercury News editorializes in favor of legalization in California. So does the East Bay Times.

The National Conference of State Legislatures endorsed rescheduling.

North Dakota will vote on MED in November. Arizona will vote on REC. Supporters of the Oklahoma MED initiative are “ cautiously optimistic” that they gathered enough signatures to make the ballot.

Two MED initiatives could qualify for the Arkansas ballot. The question of which one voters get to decide may end up in court. The Arkansas Farm Bureau and the state’s Chamber of Commerce oppose both.

Denver’s limited public use initiative collected more than double the number of signatures needed to qualify for a vote in November.

Nashville may decriminalize. The Chicago Tribune visits a grow house, and catches up on the Illinois industry.

High Times lists its “ hateful-eight,” the country’s most influential legalization opponents.

Illegal drug sales on the so-called dark web have tripled since the 2013 closure of the site Silk Road.

Watch out for knock-off vaporizers.

In Oregon, some Craigslist sellers ask for payment in cash or cannabis. Minnesota’s two MED producers are both losing money.